David S Cooper

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Subclinical thyroid disease
    David S Cooper
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Lancet 379:1142-54. 2012
  2. ncbi TSH suppressive therapy: an overview of long-term clinical consequences
    David S Cooper
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, USA
    Hormones (Athens) 9:57-9. 2010
  3. ncbi Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    David S Cooper
    The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Thyroid 19:1167-214. 2009
  4. ncbi A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal
    Pamela R Schroeder
    Johns Hopkins Medical Institutions, Division of Endocrinology and Metabolism, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 91:878-84. 2006
  5. ncbi Antithyroid drugs
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore 21215, USA
    N Engl J Med 352:905-17. 2005
  6. ncbi Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer
    Shuiying Hu
    Division of Endocrinology and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 91:98-104. 2006
  7. ncbi Subclinical thyroid disease: consensus or conundrum?
    David S Cooper
    Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, MD 21204, USA
    Clin Endocrinol (Oxf) 60:410-2. 2004
  8. ncbi The incidence and prevalence of thyroid autoimmunity
    Donald S A McLeod
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Suite 333, 1830 E Monument St, Baltimore, MD 21287, USA
    Endocrine 42:252-65. 2012
  9. ncbi Thyroid MALT lymphoma in patients with a compressive goiter
    Lisa M Earnest
    Division of Head and Neck Surgery, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    Head Neck 28:765-70. 2006
  10. ncbi Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008
    Ana B Emiliano
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, 1830 East Monument Street, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 95:2227-33. 2010

Collaborators

Detail Information

Publications18

  1. ncbi Subclinical thyroid disease
    David S Cooper
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Lancet 379:1142-54. 2012
    ..Large-scale randomised trials are urgently needed to inform how to best care for individuals with subclinical thyroid disease...
  2. ncbi TSH suppressive therapy: an overview of long-term clinical consequences
    David S Cooper
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, USA
    Hormones (Athens) 9:57-9. 2010
    ..g., osteoporosis, cardiovascular disease, diabetes), is uncertain and requires a high degree of clinical experience and judgment...
  3. ncbi Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer
    David S Cooper
    The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Thyroid 19:1167-214. 2009
    ..Since the publication of the American Thyroid Association's guidelines for the management of these disorders was published in 2006, a large amount of new information has become available, prompting a revision of the guidelines...
  4. ncbi A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal
    Pamela R Schroeder
    Johns Hopkins Medical Institutions, Division of Endocrinology and Metabolism, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 91:878-84. 2006
    ..CONCLUSIONS: Short-term hypothyroidism after L-T4 withdrawal is associated with a significant decline in quality of life that is abrogated by rhTSH use...
  5. ncbi Antithyroid drugs
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore 21215, USA
    N Engl J Med 352:905-17. 2005
  6. ncbi Detection of serum deoxyribonucleic acid methylation markers: a novel diagnostic tool for thyroid cancer
    Shuiying Hu
    Division of Endocrinology and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 91:98-104. 2006
    ..CONCLUSIONS: We have demonstrated the potential usefulness of serum DNA methylation markers as a novel tool for differential diagnosis of solid thyroid nodules and thyroid cancer recurrence monitoring...
  7. ncbi Subclinical thyroid disease: consensus or conundrum?
    David S Cooper
    Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, MD 21204, USA
    Clin Endocrinol (Oxf) 60:410-2. 2004
  8. ncbi The incidence and prevalence of thyroid autoimmunity
    Donald S A McLeod
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Suite 333, 1830 E Monument St, Baltimore, MD 21287, USA
    Endocrine 42:252-65. 2012
    ..Further research is required to assess the possibility of changing disease patterns of autoimmune thyroid disease as opposed to simple changes in diagnostic thresholds...
  9. ncbi Thyroid MALT lymphoma in patients with a compressive goiter
    Lisa M Earnest
    Division of Head and Neck Surgery, Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    Head Neck 28:765-70. 2006
    ..Two patients subsequently underwent radiation therapy. All patients are alive without evidence of disease recurrence. CONCLUSIONS: These cases are notable for the unexpected presentation of MALT lymphoma within a compressive goiter...
  10. ncbi Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008
    Ana B Emiliano
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, 1830 East Monument Street, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 95:2227-33. 2010
    ..However, little is known about the rate of use of these drugs and the prescribing practices of physicians treating hyperthyroidism...
  11. ncbi Approach to the patient with subclinical hyperthyroidism
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, 2435 West Belvedere Avenue, Hoffberger Building, Suite 56, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 92:3-9. 2007
    ..Nevertheless, it seems reasonable to treat older individuals whose serum TSH levels are less than 0.1 mU/liter and certain high-risk patients, even when the serum TSH is between 0.1 and the lower limit of the normal range...
  12. ncbi Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies
    David S Cooper
    Division of Endocrinology, Sinai Hospital of Baltimore, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 88:3474-81. 2003
  13. ncbi The use of recombinant thyrotropin in the follow-up of patients with differentiated thyroid cancer
    Milena Basaria
    Division of Endocrinology and Metabolism, Sinai Hospital of Baltimore, Maryland 21215, USA
    Am J Med 112:721-5. 2002
    ..The use of recombinant thyrotropin has fewer adverse effects than does the alternative, which is withdrawal of thyroid hormone replacement, although nausea and headache have been reported. However, recombinant thyrotropin is expensive...
  14. ncbi Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis
    Donald S A McLeod
    Division of Endocrinology and Metabolism, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Clin Endocrinol Metab 97:2682-92. 2012
    ..TSH is the major growth factor for thyrocytes and may have a causative role in thyroid cancer...
  15. ncbi Amiodarone and the thyroid
    Shehzad Basaria
    Department of Medicine, Division of Endocrinology, Johns Hopkins University School of Medicine, Bayview Medical Center, Baltimore, Maryland, USA
    Am J Med 118:706-14. 2005
    ....
  16. ncbi Amyloidosis: role of fine-needle aspiration
    Shehzad Basaria
    Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
    Thyroid 13:313-4. 2003
  17. ncbi The effect of methimazole on cure rates after radioiodine treatment for Graves' hyperthyroidism: a randomized clinical trial
    Milena Braga
    Division of Endocrinology and Metabolism, Sinai Hospital of Baltimore, Maryland 21215, USA
    Thyroid 12:135-9. 2002
    ..Similar cure rates and time required to achieve hypothyroidism after radioiodine were observed when patients were pretreated with methimazole compared to nonpretreated patients...
  18. ncbi Dirty nails
    Hans K Ghayee
    Sinai Hospital, Department of Medicine, 2401 West Belvedere Avenue, Baltimore, Maryland 21215, USA
    J Clin Endocrinol Metab 90:2428. 2005